The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Moll, R., Franke, W. W., Schiller, D. L., Geiger, B., & Krepler, R. (1982) · Cell · doi:10.1016/0092-8674(82)90400-7 · Cited by 5,247
Tumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
Self-citationThe future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,593
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Current Protocols in Immunology
(2018) · Current Protocols in Immunology · doi:10.1002/(issn)1934-368x · Cited by 3,566
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
T cell exclusion, immune privilege, and the tumor microenvironment
Joyce, J. A., & Fearon, D. T. (2015) · Science · doi:10.1126/science.aaa6204 · Cited by 2,473
Labelle, M., Begum, S., & Hynes, R. O. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.009 · Cited by 1,833
The Concept of Immunological Surveillance
Burnet, F. M. (2015) · Progress in Tumor Research · doi:10.1159/000386035 · Cited by 1,656
Contribution of platelets to tumour metastasis
Gay, L. J., & Felding-Habermann, B. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3004 · Cited by 1,645
The biology of innate lymphoid cells
Artis, D., & Spits, H. (2015) · Nature · doi:10.1038/nature14189 · Cited by 1,634
Detection of Mutations in EGFR in Circulating Lung-Cancer Cells
Maheswaran, S., Sequist, L. V., Nagrath, S., Ulkus, L., Brannigan, B., Collura, C. V., Inserra, E., Diederichs, S., Iafrate, A. J., Bell, D. W., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800668 · Cited by 1,617
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
Inhibitory B7-family molecules in the tumour microenvironment
Zou, W., & Chen, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2326 · Cited by 1,608
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,581
Adaptive immunity maintains occult cancer in an equilibrium state
Koebel, C. M., Vermi, W., Swann, J. B., Zerafa, N., Rodig, S. J., Old, L. J., Smyth, M. J., & Schreiber, R. D. (2007) · Nature · doi:10.1038/nature06309 · Cited by 1,436
Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B., Bourdeau, F., Kubes, P., & Ferri, L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67484 · Cited by 1,395
A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer
Braun, S., Vogl, F. D., Naume, B., Janni, W., Osborne, M. P., Coombes, R. C., Schlimok, G., Diel, I. J., Gerber, B., Gebauer, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050434 · Cited by 1,379
Self-citationTumor Self-Seeding by Circulating Cancer Cells
Kim, M.-Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H.-F., Norton, L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.11.025 · Cited by 1,335
Immune cell promotion of metastasis
Kitamura, T., Qian, B.-Z., & Pollard, J. W. (2015) · Nature Reviews Immunology · doi:10.1038/nri3789 · Cited by 1,158
Detection, clinical relevance and specific biological properties of disseminating tumour cells
Pantel, K., Brakenhoff, R. H., & Brandt, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2375 · Cited by 1,118
Self-citationProtection from Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule
Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., & Mountz, J. D. (1994) · Science · doi:10.1126/science.7510905 · Cited by 1,107
Immune infiltration in human tumors: a prognostic factor that should not be ignored
Pagès, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautès-Fridman, C., & Fridman, W.-H. (2010) · Oncogene · doi:10.1038/onc.2009.416 · Cited by 1,087
Natural selection of tumor variants in the generation of “tumor escape” phenotypes
Khong, H. T., & Restifo, N. P. (2002) · Nature Immunology · doi:10.1038/ni1102-999 · Cited by 1,058
Baccelli, I., Schneeweiss, A., Riethdorf, S., Stenzinger, A., Schillert, A., Vogel, V., Klein, C., Saini, M., Bäuerle, T., Wallwiener, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2576 · Cited by 1,047
Self-citationHiratsuka, S., Watanabe, A., Aburatani, H., & Maru, Y. (2006) · Nature Cell Biology · doi:10.1038/ncb1507 · Cited by 1,015
Palumbo, J. S., Talmage, K. E., Massari, J. V., La Jeunesse, C. M., Flick, M. J., Kombrinck, K. W., Jirousková, M., & Degen, J. L. (2005) · Blood · doi:10.1182/blood-2004-06-2272 · Cited by 999
Chen, L., Gibbons, D. L., Goswami, S., Cortez, M. A., Ahn, Y.-H., Byers, L. A., Zhang, X., Yi, X., Dwyer, D., Lin, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms6241 · Cited by 966
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Yu, M., Bardia, A., Aceto, N., Bersani, F., Madden, M. W., Donaldson, M. C., Desai, R., Zhu, H., Comaills, V., Zheng, Z., et al. (2014) · Science · doi:10.1126/science.1253533 · Cited by 913
Strand, S., Hofmann, W. J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., & Galle, P. R. (1996) · Nature Medicine · doi:10.1038/nm1296-1361 · Cited by 897
Increase of regulatory T cells in the peripheral blood of cancer patients.
Wolf, A. M., Wolf, D. G. F., Steurer, M., Gastl, G. A., Gunsilius, E., & Grubeck-Loebenstein, B. (2003) · PubMed · Cited by 891
Demers, M., Krause, D. S., Schatzberg, D., Martinod, K., Voorhees, J. R., Fuchs, T. A., Scadden, D. T., & Wagner, D. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200419109 · Cited by 883
The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
Galon, J., Angell, H. K., Bedognetti, D., & Marincola, F. M. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.008 · Cited by 864
Bidard, F.-C., Peeters, D. J., Fehm, T., Nolé, F., Gisbert-Criado, R., Mavroudis, D., Grisanti, S., Generali, D., Garcia-Saenz, J. A., Stebbing, J., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70069-5 · Cited by 838
Self-citationT-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
Facciabene, A., Motz, G. T., & Coukos, G. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3687 · Cited by 821
Current Protocols in Immunology
(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471142735 · Cited by 785
Takeda, K., Hayakawa, Y., Smyth, M. J., Kayagaki, N., Yamaguchi, N., Kakuta, S., Iwakura, Y., Yagita, H., & Okumura, K. (2001) · Nature Medicine · doi:10.1038/83416 · Cited by 775
T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment
Crespo, J., Sun, H., Welling, T. H., Tian, Z., & Zou, W. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.12.003 · Cited by 752
NK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
Chang, Y. S., di Tomaso, E., McDonald, D. M., Jones, R., Jain, R. K., & Munn, L. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14608 · Cited by 671
Dighe, A. S., Richards, E., Old, L. J., & Schreiber, R. D. (1994) · Immunity · doi:10.1016/1074-7613(94)90087-6 · Cited by 663
Adaptive Immune Resistance: How Cancer Protects from Immune Attack
Ribas, A. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0563 · Cited by 613
The Two Faces of Interferon-γ in Cancer
Zaidi, M. R., & Merlino, G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0482 · Cited by 593
Biology, detection, and clinical implications of circulating tumor cells
Joosse, S. A., Gorges, T. M., & Pantel, K. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201303698 · Cited by 528
Self-citationPlacke, T., Örgel, M., Schaller, M., Jung, G., Rammensee, H.-G., Kopp, H.-G., & Salih, H. R. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1872 · Cited by 458
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
Paolino, M., Choidas, A., Wallner, S., Pranjic, B., Uribesalgo, I., Loeser, S., Jamieson, A. M., Langdon, W. Y., Ikeda, F., Fededa, J. P., et al. (2014) · Nature · doi:10.1038/nature12998 · Cited by 456
Tumor-Driven Evolution of Immunosuppressive Networks during Malignant Progression
Kim, R., Emi, M., Tanabe, K., & Arihiro, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4128 · Cited by 445
Alfaro, C., Teijeira, A., Oñate, C., Pérez, G., Sanmamed, M. F., Andueza, M. P., Alignani, D., Labiano, S., Azpilikueta, A., Rodriguez-Paulete, A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2463 · Cited by 417
Romagné, F., André, P., Spee, P., Zahn, S., Anfossi, N., Gauthier, L., Capanni, M., Ruggeri, L., Benson, D. M., Blaser, B. W., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206532 · Cited by 408
NKG2D ligands in tumor immunity
Nausch, N., & Cerwenka, A. (2008) · Oncogene · doi:10.1038/onc.2008.272 · Cited by 408
Neutrophils Promote Liver Metastasis via Mac-1–Mediated Interactions with Circulating Tumor Cells
Spicer, J. D., McDonald, B., Cools-Lartigue, J. J., Chow, S. C., Giannias, B., Kubes, P., & Ferri, L. E. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2393 · Cited by 401
Braun, S., Kentenich, C., Janni, W., Hepp, F., de Waal, J., Willgeroth, F., Sommer, H., & Pantel, K. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.80 · Cited by 394
Self-citationPlatelets, protease-activated receptors, and fibrinogen in hematogenous metastasis
Camerer, E., Qazi, A. A., Duong, D. N., Cornelissen, I., Advincula, R., & Coughlin, S. R. (2004) · Blood · doi:10.1182/blood-2004-02-0434 · Cited by 386
Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
Fridman, W. H., Galon, J., Pagès, F., Tartour, E., Sautès-Fridman, C., & Kroemer, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1316 · Cited by 380
Frequent expression of PD‐L1 on circulating breast cancer cells
Mazel, M., Jacot, W., Pantel, K., Bartkowiak, K., Topart, D., Cayrefourcq, L., Rossille, D., Maudelonde, T., Fest, T., & Alix-Panabières, C. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.05.009 · Cited by 374
Self-citationEstablishment and Characterization of a Cell Line from Human Circulating Colon Cancer Cells
Cayrefourcq, L., Mazard, T., Joosse, S., Solassol, J., Ramos, J., Assenat, E., Schumacher, U., Costes, V., Maudelonde, T., Pantel, K., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2613 · Cited by 372
Self-citationThe metastasis-promoting roles of tumor-associated immune cells
Smith, H. A., & Kang, Y. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1021-5 · Cited by 367
Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer
Zhang, L., Riethdorf, S., Wu, G., Wang, T., Yang, K., Peng, G., Liu, J., & Pantel, K. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1587 · Cited by 366
Self-citationImmune-mediated dormancy: an equilibrium with cancer
Teng, M. W. L., Swann, J. B., Koebel, C. M., Schreiber, R. D., & Smyth, M. J. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107774 · Cited by 359
Contini, P., Ghio, M., Poggi, A., Filaci, G., Indiveri, F., Ferrone, S., & Puppo, F. (2003) · European Journal of Immunology · doi:10.1002/immu.200390015 · Cited by 358
Huh, S. J., Liang, S., Sharma, A., Dong, C., & Robertson, G. P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4442 · Cited by 352
Chimeric Antigen Receptor Therapy for Cancer
Barrett, D. M., Singh, N., Porter, D. L., Grupp, S. A., & June, C. H. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-060512-150254 · Cited by 349
The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
Shin, D. S., & Ribas, A. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.01.006 · Cited by 346
Hematogenous dissemination of glioblastoma multiforme
Müller, C., Holtschmidt, J., Auer, M., Heitzer, E., Lamszus, K., Schulte, A., Matschke, J., Langer-Freitag, S., Gasch, C., Stoupiec, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009095 · Cited by 328
Self-citationA Functional Role of HLA-G Expression in Human Gliomas: An Alternative Strategy of Immune Escape
Wiendl, H., Mitsdoerffer, M., Hofmeister, V., Wischhusen, J., Bornemann, A., Meyermann, R., Weiss, E. H., Melms, A., & Weller, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4772 · Cited by 325
Alsuliman, A., Colak, D., Al-Harazi, O., Fitwi, H., Tulbah, A., Al-Tweigeri, T., Al-Alwan, M., & Ghebeh, H. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0421-2 · Cited by 285
Macrophages eliminate circulating tumor cells after monoclonal antibody therapy
Gül, N., Babes, L., Siegmund, K., Korthouwer, R., Bögels, M., Braster, R., Vidarsson, G., ten Hagen, T. L. M., Kubes, P., & van Egmond, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci66776 · Cited by 275
Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells
Wu, A. A., Drake, V., Huang, H.-S., Chiu, S., & Zheng, L. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1016700 · Cited by 271
de Kruijf, E. M., Sajet, A., van Nes, J. G. H., Natanov, R., Putter, H., Smit, V. T. H. B. M., Liefers, G. J., van den Elsen, P. J., van de Velde, C. J. H., & Kuppen, P. J. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002629 · Cited by 266
Does the Immune System Naturally Protect Against Cancer?
Corthay, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00197 · Cited by 261
A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
Deng, W., Gowen, B. G., Zhang, L., Wang, L., Lau, S., Iannello, A., Xu, J., Rovis, T. L., Xiong, N., & Raulet, D. H. (2015) · Science · doi:10.1126/science.1258867 · Cited by 255
Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
Sullivan, J. P., Nahed, B. V., Madden, M. W., Oliveira, S. M., Springer, S., Bhere, D., Chi, A. S., Wakimoto, H., Rothenberg, S. M., Sequist, L. V., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0471 · Cited by 255
Programmed cell removal: a new obstacle in the road to developing cancer
Chao, M. P., Majeti, R., & Weissman, I. L. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3171 · Cited by 245
Immune Escape and Survival Mechanisms in Circulating Tumor Cells of Colorectal Cancer
Steinert, G., Schölch, S., Niemietz, T., Iwata, N., García, S. A., Behrens, B., Voigt, A., Kloor, M., Benner, A., Bork, U., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1885 · Cited by 233
Metastasis: new functional implications of platelets and megakaryocytes
Leblanc, R., & Peyruchaud, O. (2016) · Blood · doi:10.1182/blood-2016-01-636399 · Cited by 231
Pantel, K., Schlimok, G., Kutter, D., Schaller, G., Genz, T., Wiebecke, B., Backmann, R., Funke, I., & Riethmüller, G. (1991) · PubMed · Cited by 229
Self-citationGasch, C., Bauernhofer, T., Pichler, M., Langer-Freitag, S., Reeh, M., Seifert, A. M., Mauermann, O., Izbicki, J. R., Pantel, K., & Riethdorf, S. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.188557 · Cited by 227
Self-citationCedervall, J., Zhang, Y., Huang, H., Zhang, L., Femel, J., Dimberg, A., & Olsson, A.-K. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3299 · Cited by 226
Capture of Viable Circulating Tumor Cells in the Liver of Colorectal Cancer Patients
Denève, E., Riethdorf, S., Ramos, J., Nocca, D., Coffy, A., Daurès, J.-P., Maudelonde, T., Fabre, J.-M., Pantel, K., & Alix-Panabières, C. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.202846 · Cited by 226
Self-citationThe Multifaceted Role of the Microenvironment in Liver Metastasis: Biology and Clinical Implications
Van den Eynden, G. G., Majeed, A. W., Illemann, M., Vermeulen, P. B., Bird, N. C., Høyer-Hansen, G., Eefsen, R. L., Reynolds, A. R., & Brodt, P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3931 · Cited by 224
McDonald, B., Spicer, J., Giannais, B., Fallavollita, L., Brodt, P., & Ferri, L. E. (2009) · International Journal of Cancer · doi:10.1002/ijc.24409 · Cited by 222
Lee, Y., Shin, J. H., Longmire, M., Wang, H., Kohrt, H. E., Chang, H. Y., & Sunwoo, J. B. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2665 · Cited by 219
Strauss, L., Bergmann, C., & Whiteside, T. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1469 · Cited by 214
TRAIL-coated leukocytes that kill cancer cells in the circulation
Mitchell, M. J., Wayne, E., Rana, K., Schaffer, C. B., & King, M. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316312111 · Cited by 213
Natural mechanisms protecting against cancer
Jakóbisiak, M., Lasek, W., & Gołąb, J. (2003) · Immunology Letters · doi:10.1016/j.imlet.2003.08.005 · Cited by 206
TLR‐mediated activation of NK cells and their role in bacterial/viral immune responses in mammals
Adib‐Conquy, M., Scott‐Algara, D., Cavaillon, J., & Souza‐Fonseca‐Guimaraes, F. (2014) · Immunology & Cell Biology · doi:10.1038/icb.2013.99 · Cited by 203
Suppression, subversion and escape: the role of regulatory T cells in cancer progression
Oleinika, K., Nibbs, R. J., Graham, G. J., & Fraser, A. R. (2012) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2012.04657.x · Cited by 198
Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells
Wang, B., Wang, Q., Wang, Z., Jiang, J., Yu, S.-C., Ping, Y.-F., Yang, J., Xu, S.-L., Ye, X.-Z., Xu, C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2563 · Cited by 198
Chao, M. P., Tang, C., Pachynski, R. K., Chin, R., Majeti, R., & Weissman, I. L. (2011) · Blood · doi:10.1182/blood-2011-02-338020 · Cited by 194
Role of natural killer cells in control of cancer metastasis
Hanna, N. (1982) · Cancer and Metastasis Review · doi:10.1007/bf00049480 · Cited by 190
Barsoum, I. B., Hamilton, T. K., Li, X., Cotechini, T., Miles, E. A., Siemens, D. R., & Graham, C. H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2104 · Cited by 188
Benson, D. M., Cohen, A. D., Jagannath, S., Munshi, N. C., Spitzer, G., Hofmeister, C. C., Efebera, Y. A., Andre, P., Zerbib, R., & Caligiuri, M. A. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0304 · Cited by 180
Crane, C. A., Austgen, K., Haberthur, K., Hofmann, C., Moyes, K. W., Avanesyan, L., Fong, L., Campbell, M. J., Cooper, S., Oakes, S. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413933111 · Cited by 174
Detection of Brain Tumor Cells in the Peripheral Blood by a Telomerase Promoter-Based Assay
MacArthur, K. M., Kao, G. D., Chandrasekaran, S., Alonso-Basanta, M., Chapman, C., Lustig, R. A., Wileyto, E. P., Hahn, S. M., & Dorsey, J. F. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-0813 · Cited by 172
Jiang, H., Gebhardt, C., Umansky, L., Beckhove, P., Schulze, T. J., Utikal, J., & Umansky, V. (2015) · International Journal of Cancer · doi:10.1002/ijc.29297 · Cited by 169
Fas and Fas Ligand Interactions Suppress Melanoma Lung Metastasis
Owen-Schaub, L. B., van Golen, K. L., Hill, L. L., & Price, J. E. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1717 · Cited by 168
Circulating and Disseminated Tumor Cells
Braun, S., & Naume, B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.073 · Cited by 160
Role of non-classical MHC class I molecules in cancer immunosuppression
Kochan, G., Escors, D., Breckpot, K., & Guerrero-Setas, D. (2013) · OncoImmunology · doi:10.4161/onci.26491 · Cited by 159
Ock, C.-Y., Kim, S., Keam, B., Kim, M., Kim, T. M., Kim, J.-H., Jeon, Y. K., Lee, J., Kwon, S. K., Hah, J. H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7431 · Cited by 154
Kallergi, G., Markomanolaki, H., Giannoukaraki, V., Papadaki, M. A., Strati, A. D., Lianidou, E. S., Georgoulias, V., Mavroudis, D., & Agelaki, S. (2009) · Breast Cancer Research · doi:10.1186/bcr2452 · Cited by 152
Bayón, L. G., Izquierdo, M. A., Sirovich, I., van Rooijen, N., Beelen, R. H. J., & Meijer, S. (1996) · Hepatology · doi:10.1002/hep.510230542 · Cited by 150
Agaugué, S., Carosella, E. D., & Rouas‐Freiss, N. (2011) · Blood · doi:10.1182/blood-2010-07-294389 · Cited by 142
Lin, A., & Yan, W. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00083 · Cited by 137
Variant isoforms of CD44 are P‐ and L‐selectin ligands on colon carcinoma cells
Hanley, W. D., Napier, S. L., Burdick, M. M., Schnaar, R. L., Sackstein, R., & Κωνσταντόπουλος, Κ. (2005) · The FASEB Journal · doi:10.1096/fj.05-4574fje · Cited by 133
Role of Altered Expression of HLA Class I Molecules in Cancer Progression
Aptsiauri, N., Cabrera, T., Méndez, R., Garcia-Lor, A., Ruiz‐Cabello, F., & Garrido, F. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72005-0_13 · Cited by 132
Giorgi, U. D., Mego, M., Scarpi, E., Giuliano, M., Giordano, A., Reuben, J. M., Valero, V., Ueno, N. T., Hortobágyi, G. N., & Cristofanilli, M. (2012) · Clinical Breast Cancer · doi:10.1016/j.clbc.2012.04.004 · Cited by 132
A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells
Dimitroff, C. J., Lee, J. Y., Fuhlbrigge, R. C., & Sackstein, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250484797 · Cited by 128
Prognostic significance of regulatory T cells in tumor
Wilke, C. M., Wu, K., Zhao, E., Wang, G., & Zou, W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25464 · Cited by 124
Cohen, E. N., Gao, H., Anfossi, S., Mego, M., Reddy, N. G., Debeb, B. G., Giordano, A., Tin, S., Wu, Q., Garza, R. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132710 · Cited by 116
Oliveira–Costa, J. P., de Carvalho, A. F., da Silveira, G. G., Amaya, P., Wu, Y., Park, K. J., Pinilla, M. G., Lustberg, M. B., Buim, M. E. C., Ferreira, E. N., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3939 · Cited by 116
PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma
Wang, Y., Wang, H., Zhao, Q., Xia, Y., Hu, X., & Guo, J. (2015) · Medical Oncology · doi:10.1007/s12032-015-0655-2 · Cited by 114
Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR
Strati, A. D., Markou, A. N., Parisi, C., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-422 · Cited by 107
Cai, M., Xu, Y., Qiu, S., Ju, M., Gao, Q., Li, Y.-W., Zhang, B., Zhou, J., & Fan, J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0463 · Cited by 106
Bellora, F., Castriconi, R., Dondero, A., Pessino, A. M., Nencioni, A., Liggieri, G., Moretta, L., Mantovani, A., Moretta, A., & Bottino, C. (2014) · European Journal of Immunology · doi:10.1002/eji.201344130 · Cited by 104
Jewett, A., & Tseng, H.-C. (2011) · Journal of Cancer · doi:10.7150/jca.2.443 · Cited by 103
Pantel, K., & Alix‐Panabières, C. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2014.79 · Cited by 96
Self-citationPredictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients
Guo, Z., Lv, Y., Wang, L., Shi, S., Yang, F., Zheng, G., Wen, W., & Yang, A. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.10.003 · Cited by 95
Fas and Fas ligand interactions in malignant disease.
Owen‐Schaub, L. B., Chan, H. H. L., Cusack, J. C., Roth, J. A., & Hill, L. L. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.1.5 · Cited by 95
Baccelli, I., Stenzinger, A., Vogel, V., Pfitzner, B. M., Klein, C., Wallwiener, M., Scharpff, M., Saini, M., Holland‐Letz, T., Sinn, H., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2385 · Cited by 91
Naume, B., Synnestvedt, M., Falk, R. S., Wiedswang, G., Weyde, K., Risberg, T., Kersten, C., Mjaaland, I., Vindi, L., Sommer, H., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.9327 · Cited by 90
The Fas/Fas‐ligand system: a mechanism for immune evasion in human breast carcinomas
Gutierrez, L. S., Eliza, M., Niven‐Fairchild, T., Naftolin, F. N., & Mor, G. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006102601215 · Cited by 89
Mego, M., Gao, H., Cohen, E. N., Anfossi, S., Giordano, A., Sanda, T., Fouad, T. M., Giorgi, U. D., Giuliano, M., Woodward, W. A., et al. (2016) · Journal of Cancer · doi:10.7150/jca.13098 · Cited by 88
Strell, C., Lang, K., Niggemann, B., Zaenker, K. S., & Entschladen, F. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.09.003 · Cited by 85
Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?
Lee, N., Barthel, S. R., & Schatton, T. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.116 · Cited by 85
Loumagne, L., Baudhuin, J., Favier, B., Montespan, F., Carosella, E. D., & Rouas‐Freiss, N. (2014) · International Journal of Cancer · doi:10.1002/ijc.28845 · Cited by 83
Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients.
Ugurel, S., Rappl, G., Tilgen, W., & Reinhold, U. (2001) · PubMed · Cited by 83
König, L., Kasimir‐Bauer, S., Hoffmann, O., Bittner, A., Wagner, B., Manvailer, L. F. S., Schramm, S., Bánkfalvi, Á., Giebel, B., Kimmig, R., et al. (2016) · Human Immunology · doi:10.1016/j.humimm.2016.01.002 · Cited by 82
Hallermalm, K., Geer, A. D., Kiessling, R. W., Levitsky, V., & Levitskaya, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0508 · Cited by 79
Bartkowiak, K., Kwiatkowski, M., Buck, F., Gorges, T. M., Nilse, L., Assmann, V., Andreas, A., Müller, V., Wikman, H., Riethdorf, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3728 · Cited by 79
Self-citationCD44 and HCELL: Preventing hematogenous metastasis at step 1
Jacobs, P. P., & Sackstein, R. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.07.039 · Cited by 77
Dong, C., Slattery, M. J., Liang, S., & Peng, H. (2005) · PubMed · Cited by 76
Mego, M., Gao, H., Lee, B.-N., Cohen, E. N., Tin, S., Giordano, A., Wu, Q., Liu, P., Nieto, Y. L., Champlin, R. E., et al. (2012) · Journal of Cancer · doi:10.7150/jca.5111 · Cited by 68
Mego, M., Cholujová, D., Minárik, G., Sedláčková, T., Gronesova, P., Karaba, M., Benca, J., Cingelová, S., Čierna, Z., Manasova, D., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2143-2 · Cited by 66
Brodbeck, T., Nehmann, N., Bethge, A., Wedemann, G., & Schumacher, U. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-244 · Cited by 65
Allergic Pulmonary Inflammation Promotes the Recruitment of Circulating Tumor Cells to the Lung
Taranova, A. G., Maldonado, D., Vachon, C. M., Jacobsen, E. A., Abdala‐Valencia, H., McGarry, M. P., Ochkur, S. I., Protheroe, C. A., Doyle, A. D., Grant, C. S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1673 · Cited by 64
Gruber, I. V., Landenberger, N., Staebler, A., Hahn, M., Wallwiener, D. R., & Fehm, T. N. (2013) · PubMed · Cited by 62
Crosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment
Noman, M. Z., Messai, Y., Muret, J. C., Hasmim, M., & Chouaïb, S. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0157-3 · Cited by 61
Connelly, L., Barham, W. J., Onishko, H. M., Chen, L., Sherrill, T. P., Zabuawala, T., Ostrowski, M. C., Blackwell, T. S., & Yull, F. E. (2011) · Breast Cancer Research · doi:10.1186/bcr2935 · Cited by 60
Santos, M. F., Mannam, V. K. R., Craft, B. S., Puneky, L. V., Sheehan, N. T., Lewis, R. E., & Cruse, J. M. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.04.001 · Cited by 57
Tseng, J.-Y., Yang, C., Liang, S.-C., Liu, R.-S., Yang, S.-H., Lin, J.-K., Chen, Y.-M., Wu, Y., Jiang, J., & Lin, C.-H. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2162 · Cited by 57
PARP-1 Controls Immunosuppressive Function of Regulatory T Cells by Destabilizing Foxp3
Zhang, P., Maruyama, T., Konkel, J. E., Abbatiello, B., Zamarron, B. F., Wang, Z., & Chen, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071590 · Cited by 49
Gruber, I. V., Yousfi, S., Dürr-Störzer, S., Wallwiener, D. R., Solomayer, E., & Fehm, T. N. (2008) · PubMed · Cited by 48
Gordon, N. B., & Kleinerman, E. S. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_29 · Cited by 45
Hensler, M., Vančurová, I., Becht, É., Palata, O., Strnad, P., Tesařová, P., Čabiňaková, M., Švec, D., Kubista, M., Bartůňková, J., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1102827 · Cited by 41
Green, T. L., Cruse, J. M., & Lewis, R. E. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.06.013 · Cited by 39
Green, T. L., Santos, M. F., Ejaeidi, A. A., Craft, B. S., Lewis, R. E., & Cruse, J. M. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.05.003 · Cited by 39
Predominant Expression of Fas (CD95) Ligand in Metastatic Melanoma Revealed by Longitudinal Analysis
Terheyden, P. A. M., Siedel, C., Merkel, A., Kämpgen, E., Bröcker, E., & Becker, J. C. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00607.x · Cited by 36
Fas Ligand Expression Is Correlated with Metastasis in Colorectal Carcinoma
Nozoe, T., Yasuda, M., Honda, M., Inutsuka, S., & Korenaga, D. (2003) · Oncology · doi:10.1159/000071208 · Cited by 34
Stojadinovic, A., Mittendorf, E. A., Holmes, J. P., et al. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9538-x · Cited by 28
Cole, S., Montero, A. J., Garret-Mayer, E., Onicescu, G., Vandenberg, T., Hutchens, S., & Diaz-Montero, C. M. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-09-4135 · Cited by 24
Bartkowiak, K., Riethdorf, S., & Pantel, K. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0067-6 · Cited by 23
Self-citationTumor cell dissemination patterns and metastasis of murine mammary carcinoma.
Juaçaba, S. F., Horak, E., Price, J. E., & Tarin, D. (1989) · PubMed · Cited by 22
PD-L1 expression by circulating breast cancer cells
David, R. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00074-1 · Cited by 21
Jannasch, K., Wegwitz, F., Lenfert, E., Maenz, C., Deppert, W., & Alves, F. (2014) · International Journal of Cancer · doi:10.1002/ijc.29369 · Cited by 16
Stanzer, S., Dandachi, N., Balić, M., Resel, M., Samonigg, H., & Bauernhofer, T. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9139-2 · Cited by 13
Cited by
Current and future perspectives of liquid biopsies in genomics-driven oncology
Heitzer, E., Haque, I. S., Roberts, C. E. S., & Speicher, M. R. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0071-5 · Cited by 1,557
Neutrophils escort circulating tumour cells to enable cell cycle progression
Szczerba, B. M., Castro-Giner, F., Vetter, M., Krol, I., Gkountela, S., Landin, J., Scheidmann, M. C., Donato, C., Scherrer, R., Singer, J., et al. (2019) · Nature · doi:10.1038/s41586-019-0915-y · Cited by 1,225
Liquid biopsy and minimal residual disease - latest advances and implications for cure
Pantel, K., & Alix-Panabières, C. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0187-3 · Cited by 1,110
Self-citationGanesh, K., & Massagué, J. (2021) · Nature Medicine · doi:10.1038/s41591-020-01195-4 · Cited by 1,051
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Gao, W., Wang, X., Zhou, Y., Wang, X., & Yu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01046-3 · Cited by 1,042
Metadata
- Authors
- Mohme, M., Riethdorf, S., & Pantel, K.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2016-09-20
- Volume
- 14
- Issue
- 3
- Pages
- 155-167
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2521381098
- Cited by
- 602
- References
- 164
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.